| BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ... Cancer cell 33 (3), 401-416. e8, 2018 | 243 | 2018 |
| Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science translational medicine 9 (392), 2017 | 197 | 2017 |
| Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis Y Meng, W Lu, E Guo, J Liu, B Yang, P Wu, S Lin, T Peng, Y Fu, F Li, ... Journal of hematology & oncology 13, 1-11, 2020 | 181 | 2020 |
| miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition C Sun, N Li, Z Yang, B Zhou, Y He, D Weng, Y Fang, P Wu, P Chen, ... Journal of the National Cancer Institute 105 (22), 1750-1758, 2013 | 181 | 2013 |
| Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy Y Fang, DJ McGrail, C Sun, M Labrie, X Chen, D Zhang, Z Ju, CP Vellano, ... Cancer cell 35 (6), 851-867. e7, 2019 | 180 | 2019 |
| Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, ... Journal of Experimental Medicine 216 (3), 688-703, 2019 | 173 | 2019 |
| The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis C Sun, N Li, D Ding, D Weng, L Meng, G Chen, D Ma PloS one 9 (5), e95285, 2014 | 116 | 2014 |
| miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1 F Kong, C Sun, Z Wang, L Han, D Weng, Y Lu, G Chen Journal of Huazhong University of Science and Technology [Medical Sciences …, 2011 | 109 | 2011 |
| The biodiversity composition of microbiome in ovarian carcinoma patients B Zhou, C Sun, J Huang, M Xia, E Guo, N Li, H Lu, W Shan, Y Wu, Y Li, ... Scientific reports 9 (1), 1691, 2019 | 108 | 2019 |
| Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis C Sun, G Chen, Z Yang, J Jiang, X Yang, N Li, B Zhou, T Zhu, J Wei, ... Fertility and sterility 100 (3), 782-787. e5, 2013 | 90 | 2013 |
| The trans-omics landscape of COVID-19 P Wu, D Chen, W Ding, P Wu, H Hou, Y Bai, Y Zhou, K Li, S Xiang, P Liu, ... Nature Communications 12 (1), 4543, 2021 | 83 | 2021 |
| Metformin suppresses tumor progression by inactivating stromal fibroblasts in ovarian cancer S Xu, Z Yang, P Jin, X Yang, X Li, X Wei, Y Wang, S Long, T Zhang, ... Molecular cancer therapeutics 17 (6), 1291-1302, 2018 | 83 | 2018 |
| Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer N Li, C Sun, B Zhou, H Xing, D Ma, G Chen, D Weng PLoS One 9 (7), e100314, 2014 | 82 | 2014 |
| Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways B Zhou, C Sun, N Li, W Shan, H Lu, L Guo, E Guo, M Xia, D Weng, ... International journal of oncology 48 (5), 2087-2097, 2016 | 81 | 2016 |
| Proteome instability is a therapeutic vulnerability in mismatch repair-deficient cancer DJ McGrail, J Garnett, J Yin, H Dai, DJH Shih, TNA Lam, Y Li, C Sun, Y Li, ... Cancer cell 37 (3), 371-386. e12, 2020 | 77 | 2020 |
| Retracted: Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling Z Yang, Y Liu, J Liao, C Gong, C Sun, X Zhou, X Wei, T Zhang, Q Gao, ... The FEBS journal 282 (6), 1111-1125, 2015 | 71 | 2015 |
| MYC and the unfolded protein response in cancer: synthetic lethal partners in crime? T Zhang, N Li, C Sun, Y Jin, X Sheng EMBO Molecular Medicine 12 (5), e11845, 2020 | 66 | 2020 |
| miR‑222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1 C Sun, NA Li, BO Zhou, Z Yang, D Ding, D Weng, L Meng, S Wang, ... Oncology letters 6 (2), 507-512, 2013 | 64 | 2013 |
| MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis C Sun, X Li, E Guo, N Li, B Zhou, H Lu, J Huang, M Xia, W Shan, B Wang, ... Oncogene 39 (8), 1681-1695, 2020 | 58 | 2020 |
| Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression Z Yang, X Yang, S Xu, P Jin, X Li, X Wei, D Liu, K Huang, S Long, Y Wang, ... Molecular cancer 16, 1-15, 2017 | 54 | 2017 |
